Fig. 3From: Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhageForest plot. A priori subgroup analysis for favorable GOSE (5 to 8) at 6 months. n, number with favorable GOSE in each subgroup. N, total number randomized in each subgroup. TE, treatment effect. WFNS, World Federation of Neurosurgical SocietiesBack to article page